NDC 0069-0187

Ibrance

Palbociclib

Ibrance is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Palbociclib.

• Product ID: 0069-0187_54fa32a8-a9aa-4643-a227-ddf95ec4dd05
• NDC: 0069-0187
• Product Type: Human Prescription Drug
• Proprietary Name: Ibrance
• Generic Name: Palbociclib
• Dosage Form: Capsule
• Route of Administration: ORAL
• Marketing Start Date: 2015-02-03
• Marketing Category: NDA / NDA
• Application Number: NDA207103
• Labeler Name: Pfizer Laboratories Div Pfizer Inc
• Substance Name: PALBOCICLIB
• Active Ingredient Strength: 75 mg/1
• Pharm Classes: Kinase Inhibitor [EPC],Kinase Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 0069-0187-21

21 CAPSULE in 1 BOTTLE (0069-0187-21)

• Marketing Start Date: 2015-02-03
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0069-0187-21 [00069018721]

Ibrance CAPSULE

• Marketing Category: NDA
• Application Number: NDA207103
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2015-02-03

Drug Details

Active Ingredients

Ingredient	Strength
PALBOCICLIB	75 mg/1

Pharmacological Class

• Kinase Inhibitor [EPC]
• Kinase Inhibitors [MoA]
• Cytochrome P450 3A Inhibitors [MoA]

NDC Crossover Matching brand name "Ibrance" or generic name "Palbociclib"

NDC	Brand Name	Generic Name
0069-0187	Ibrance	palbociclib
0069-0188	Ibrance	palbociclib
0069-0189	Ibrance	palbociclib
0069-0284	Ibrance	palbociclib
0069-0486	Ibrance	palbociclib
0069-0688	Ibrance	palbociclib
63539-187	Ibrance	palbociclib
63539-188	Ibrance	palbociclib
63539-189	Ibrance	palbociclib
63539-284	Ibrance	palbociclib
63539-486	Ibrance	palbociclib
63539-688	Ibrance	palbociclib